Better visual acuity with FLACS

Patient treated with FLACS had significantly better uncorrected visual acuity three hours after surgery than those treated with conventional phaco cataract surgery

Better visual acuity with FLACS
Howard Larkin
Howard Larkin
Published: Sunday, May 7, 2017
Karl Stonecipher MD
Patients treated with femtosecond laser-assisted cataract surgery (FLACS) had significantly better uncorrected visual acuity (UCVA) three hours after surgery than those treated with conventional phaco cataract surgery, Karl Stonecipher MD told the 2017 ASCRS•ASOA Symposium & Congress in Los Angeles, USA. Mean UCVA for 1,015 FLACS patients was 20/32 compared with 20/50 for 761 conventional phaco patients. “At three months they were comparable but my patients want to see instantly,” said Dr Stonecipher, of the University of North Carolina. The FLACS group also required significantly less ultrasound energy and time, he noted.
My patients want to see instantly
Patients with LOCS Grade II cataracts treated as part of the USFREE trial showed similar results, said Alfredo Tranjan Neto MD of Sao Paulo, Brazil. In a randomized interventional study 52 FLACS eyes achieved a mean best corrected visual acuity (BCVA) of 0.08 ±0.14 logMAR, or nearly 20/20, compared with 0.20 ±0.23, or about 20/32, for 52 conventional phaco eyes (P=0.00016). Dr Neto also reported significantly higher endothelial cell density in the FLACS group 30 days after surgery, with a mean 2,401.58 ±463.03 compared with 2,100.04 ±565.74 in the conventional phaco group (P=0.0051). At zero, phaco energy in the FLACS group was also significantly lower, while the volume of balanced salt solution used and surgical time were similar between the two groups. FLACS is potentially a safer procedure than conventional phaco cataract surgery and offers faster recovery time in patients with Grade II nuclei, Dr Neto concluded.                            
Latest Articles
ESCRS Today 2025: Happy Anniversaries!

ESCRS celebrates milestones with pioneers in IOLs, LASIK, femtosecond lasers, and corneal transplantation.

Read more...

ESCRS Today 2025: A Congress for Everyone

From YOs to families, the ESCRS Annual Meeting embraces full participation through inclusivity.

Read more...

ESCRS Today 2025: All Eyes on Innovation

Watching out for obstacles and opportunities

Read more...

Beyond the Numbers

Empowering patient participation fosters continuous innovation in cataract surgery.

Read more...

Thinking Beyond the Surgery Room

Practice management workshop focuses on financial operations and AI business applications.

Read more...

Aid Cuts Threaten Global Eye Care Progress

USAID closure leads retreat in development assistance.

Read more...

Supplement: ESCRS Clinical Trends Series: Presbyopia

Read more...

Debate: FS-LASIK or KLEx for Hyperopia?

FS-LASIK has more of a track record, but KLEx offers advantages.

Read more...

Four AI Applications Ready for Practice

Commercial offerings may save time, improve practice and research.

Read more...

Perioperative Medication Regimens for Cataract Surgery

Randomised controlled clinical trial results provide evidence-based guidance.

Read more...